{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidhvz5uxxwx7yl6z7ut36uxpd6hhc54pkid5neeicwlnlq3sjj7yi",
    "uri": "at://did:plc:tr4cib3u27qz5ltiassjlr7b/app.bsky.feed.post/3mhqh2ynepyx2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaxixo2vagtmbtko4k4zemzk3ipfpcz3ght3qprzqxbiiymvh6kmy"
    },
    "mimeType": "image/jpeg",
    "size": 136409
  },
  "path": "/healthfit/2026/03/drug-discovered-at-ohio-university-may-improve-lung-cancer-outcomes.html",
  "publishedAt": "2026-03-23T16:00:55.000Z",
  "site": "https://www.cleveland.com",
  "textContent": "Pegvisomant, developed by professor John Kopchick in 1987, shows potential to make treatment-resistant lung cancer cells more sensitive to chemotherapy when used in combination.",
  "title": "Drug discovered at Ohio University may improve lung cancer outcomes"
}